
Peking University First Hospital has a total capacity of 1,805 beds across three campuses: Central, Miyun, and Daxing. The hospital delivers a full range of inpatient and outpatient services, serving patients across China and internationally.
Established in 1915, Peking University First Hospital (PUFH) is one of China's most prestigious medical institutions, affiliated with the Peking University Health Science Center. As a top-tier tertiary hospital classified as Grade 3A, it is recognized for its leadership in clinical excellence, education, and research. Over the decades, PUFH has been pioneering in shaping modern Chinese medicine, particularly in specialties such as urology, nephrology, pediatrics, neurology, cardiology, and organ transplantation.
The hospital is home to a team of highly qualified doctors and professors, including many national-level experts. Known for managing complex and rare diseases, it continues to advance patient care through innovation, multidisciplinary collaboration, and compassionate treatment.
Advanced Technology & Facilities
Key Services at Peking University First Hospital
Peking University First Hospital blends a century of medical heritage with high-quality clinical care, innovative research, and comprehensive education. It stands as a benchmark of excellence in China, committed to improving patient outcomes through multidisciplinary collaboration and compassionate, personalized care.

The hospital has approximately 50 inpatient beds in its main campus, along with nine satellite clinics across Beijing. It manages over 2,500 outpatient visits each week and provides care to hundreds of thousands of patients annually, both local and international.
Beijing United Family Hospital (BJU) is one of China’s most prestigious private medical institutions, known for delivering world-class healthcare that meets international standards. Established in 1997, it was the first foreign-invested hospital in China and has since become a trusted choice for both International and Chinese patients seeking high-quality, patient-focused care. As part of the United Family Healthcare network, BJU has built a reputation for medical excellence, advanced technology, and a uniquely personalized approach to treatment.
The hospital is staffed by a diverse team of internationally trained doctors, many of whom have practiced in top healthcare systems across the U.S., Europe, and Asia. This global expertise is complemented by the latest medical equipment, multilingual support services, and a strong commitment to clinical safety and patient satisfaction. Recognized by the Joint Commission International (JCI) for meeting the highest standards in healthcare delivery, BJU offers a full spectrum of medical services across numerous specialties, including family medicine, internal medicine, orthopedics, oncology, cardiology, obstetrics, pediatrics, and plastic surgery.
Advanced Technology & Facilities
Key Services at BJU
Beijing United Family Hospital stands as a pioneer in international-standard healthcare in China, blending modern technology, world-class medical expertise, and a warm, comprehensive approach to family health.

As part of Singapore‑listed Raffles Medical Group, founded in 1976, RMG China operates 5 tertiary hospitals and over 100 clinics, supported by 430+ physicians and 900+ nurses & allied health professionals, delivering comprehensive inpatient and outpatient services.
Raffles Medical Group has operated in China since 2010, growing into a trusted name among both local and expatriate communities. All RMG China hospitals and clinics follow the Group’s Institutional Group Practice Model, which emphasizes integrated, peer-reviewed, and clinically audited care. Backed by Raffles Hospital Singapore, accredited by Joint Commission International (JCI), the network ensures alignment with global standards for quality and patient safety. With a rigorous clinical governance framework, strategic insurance and corporate partnerships, and a presence in key Chinese cities, RMG serves over 2.8 million patients annually. The Group continues to expand across China, offering world-class healthcare that combines international expertise with localized, patient-centered care.
Advanced Technology & Facilities
Key Services at Raffles Medical Group China
Raffles Medical Group China is a leading integrated private hospital network, delivering high-quality, multidisciplinary medical care in major Chinese cities. With its robust institutional infrastructure, advanced diagnostic and treatment facilities, and a reputation anchored by the Singapore-based Raffles Hospital, RMG China continues to expand and uphold global healthcare standards.

GoBroad Healthcare Group, founded in 2017, is a leading medical network in China, specializing in the treatment of complex hematologic diseases and solid tumors. The group integrates clinical treatment, research, reference laboratories, and medical information technology under an Academic Research Organization model. With seven hospitals across Beijing, Shanghai, and Guangzhou, it provides advanced therapies including CAR-T cell therapy, hematopoietic stem cell transplantation, chemotherapy, radiotherapy, and targeted therapy. Its multidisciplinary teams ensure that patients receive comprehensive and personalized treatment for both common and rare conditions. The group is known for its patient-centered approach by combining modern medical science with innovative therapies and long-term follow-up care. With international collaborations, multilingual staff, and dedicated global patient services, it has become a trusted choice for individuals seeking specialized cancer and hematology treatments in China. By focusing on research-driven medicine, advanced facilities, and supportive care, GoBroad Healthcare Group continues to enhance patient survival, recovery, and long-term quality of life.
Advanced Technology & Facilities
Key Services



China has developed a strong reputation for cancer screening due to its large population based programs, advanced diagnostic technology, and highly trained preventive oncology teams. Major hospitals use standardized screening pathways supported by accreditation and safety standards, including quality control for imaging, endoscopy, and laboratory testing. These clinics often combine imaging, biomarker testing, and clinical evaluation to tailor screening plans based on age, family history, and lifestyle risk factors.
Cancer screening in China typically ranges from USD 400 to USD 4,200, depending on the number of tests included and the level of hospital providing care. Costs can vary based on imaging type, such as low dose CT or MRI, use of endoscopy, genetic risk assessment, and specialist review. Most patients resume desk work or travel within 1 to 3 days after standard screening, while procedures like colonoscopy may require short recovery time. Not every patient is an ideal candidate for every test, so each case requires individual assessment and a tailored screening plan by the clinic team.
This information is for educational purposes and does not replace an in person consultation with a qualified specialist.
Cancer screening clinics in China generally operate within large tertiary hospitals that follow structured patient pathways. These centers emphasize experienced multidisciplinary teams, clean and regulated facilities, and clear protocols for follow up when abnormal findings are detected.
Peking University Cancer Hospital in Beijing is a leading center for cancer screening and prevention. The hospital offers structured programs for lung, breast, gastrointestinal, and cervical cancers using low dose CT scans, mammography, endoscopy, biomarker testing, and genetic risk assessment. Its strength lies in integrating screening with patient education and clear follow up policies to manage potential risks such as false positive results.
Peking Union Medical College Hospital in Beijing provides comprehensive cancer screening services, particularly for gastrointestinal, liver, and hematologic cancers. The hospital emphasizes safety standards, careful test selection, and multidisciplinary review of results. Patients benefit from coordinated care pathways that link screening findings with specialist consultation when needed.
Fudan University Shanghai Cancer Center is widely recognized for preventive oncology and cancer screening programs. The center focuses on gastrointestinal, breast, cervical, and liver cancers using advanced imaging, endoscopic procedures, and biomarker testing. Follow up policies are clearly defined, helping patients understand next steps after screening and reducing uncertainty during the evaluation process.
Best Clinic Abroad supports international patients who are considering cancer screening in China. The team helps connect you with verified clinics, clarify screening options, and coordinate key details around your medical visit.
➤ Initial virtual consultation - Arrange an online discussion so clinics can review risk factors and recommend appropriate screening plans.
➤ Clear package information - Secure transparent price ranges and explanations of what screening packages typically include.
➤ Medical file coordination - Help organize prior imaging and test results so clinics can assess candidacy before travel.
If you are exploring cancer screening in China, you can start by sharing your health background with Best Clinic Abroad and receive guided support in choosing a suitable clinic and planning next steps.
Question: Who is considered an ideal candidate for cancer screening programs in China?
Answer: Screening is often recommended for people with higher risk due to age, family history, lifestyle factors, or prior medical conditions, but specialist evaluation is essential.
Question: Are there risks associated with cancer screening tests?
Answer: Some tests may cause temporary discomfort or lead to false positive results, which is why clinics follow safety protocols and structured follow up processes.